Redsense receives largest order to date – sales growth trend continues
Redsense Medical announces today that the company has secured its largest single order ever. The record order, received from one of the company’s US distributors, is worth MSEK 3.1 and will bring Redsense’s sales for the second quarter to a new record high, surpassing Q1 2020.
“We are proud and excited to receive this landmark order. The value of this order alone exceeds the total order intake during the corresponding period last year, Q2 2019, which totalled MSEK 2.7,” saysPatrik Byhmer, CEO of Redsense Medical AB: “The Redsense technology is well proven in the US market, and we are continuously working to increase the safety of patients; considering the global turmoil in the wake of the pandemic, our unbroken growth trend is a humbling feat that speaks volumes about the great confidence that our customers place in us.”
For more information, please contact:
Patrik Byhmer, CEO Redsense Medical AB (publ)
Phone: +46 35 10 60 30
ABOUT REDSENSE MEDICAL
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovationused for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.
This information is such information that Redsense Medical AB (publ) is obligated to publish in compliance with the EU market abuse regulation. This information was provided, through the above contact, for publication on 09 June 2020.